title: N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial.
abstract: OBJECTIVE
  The aim of the study was to investigate whether omega-3 fatty acids (n-3 FA) reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty.
  
  
  BACKGROUND
  Meta-analyses have shown significant reduction of restenosis after coronary angioplasty upon supplementation with n-3 FA.
  
  
  METHODS
  In a prospective, placebo-controlled, double-blind study, 500 patients were randomly allocated to treatment with n-3 FA (Omacor, Pronova AS, Oslo, Norway) 5.1 g/day or corn oil (placebo) starting at least two weeks prior to elective coronary angioplasty. The treatment was continued until restenosis evaluation by quantitative coronary angiography after six months. Stenosis was defined as a minimal luminal diameter (MLD) < 40% of the reference diameter. Successful coronary angioplasty was defined as > or = 20% acute gain in MLD and a residual stenosis < 50%. Restenosis was defined as > or = 20% late loss of diameter and stenosis > 50% or an increase in stenosis of > or = 0.7 mm. Three-hundred ninety-two patients fulfilled the criteria for initial stenosis and successful coronary angioplasty, and, except four patients who died, none were lost for follow-up.
  
  
  RESULTS
  Restenosis occurred in 108/266 (40.6%) of the treated stenoses in the Omacor group and in 93/263 (35.4%) in the placebo group (odds ratio [OR] 1.25, 95% confidence interval [CI] [0.87-1.80] p = 0.21). In the Omacor group one or more restenoses occurred in 90/196 (45.9%) patients as compared with 86/192 (44.8%) in the placebo group (OR 1.05, 95% CI [0.69-1.59] p = 0.82).
  
  
  CONCLUSIONS
  Supplementation with 5.1 g n-3 FA/day for six months, initiated at least two weeks prior to coronary angioplasty did not reduce the incidence of restenosis.
authors.affiliation: Department of Cardiology, Ullevaal University Hospital, Oslo, Norway. odd.johansen@ioks.uio.no
authors.forename: O
authors.initials: O
authors.lastname: Johansen
authors.forename: M
authors.initials: M
authors.lastname: Brekke
authors.forename: I
authors.initials: I
authors.lastname: Seljeflot
authors.forename: M
authors.initials: M
authors.lastname: Abdelnoor
authors.forename: H
authors.initials: H
authors.lastname: Arnesen
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000818:Animals; D003314:Corn Oil / Q000008:administration & dosage; D017023:Coronary Angiography; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000628:therapy*; D004311:Double-Blind Method; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011292:Premedication; D011446:Prospective Studies; D012008:Recurrence; D017211:Treatment Failure
chemical_list: D015525:Fatty Acids, Omega-3; D003314:Corn Oil